首页 > 最新文献

Nederlands tijdschrift voor geneeskunde最新文献

英文 中文
[A patient with an acute swelling in the neck after coronary angiography]. [冠状动脉造影后颈部出现急性肿胀的病人]。
Q4 Medicine Pub Date : 2025-09-24
Ruben Y Gabriëls, Merel van Sante, Vincent C Cappendijk

A 72-year-old man with no relevant medical history underwent coronary angiography for angina complaints. One day post-procedure, he developed a progressive, painless right-sided neck swelling. Ultrasound revealed a well-defined 30.1 mm cyst in the right thyroid lobe without connection to the carotid artery or signs of aneurysm. Diagnosis: thyroid cyst haemorrhage.

72岁男性,无相关病史,因心绞痛主诉行冠状动脉造影。术后一天,患者右侧颈部出现渐进性无痛性肿胀。超声显示右甲状腺叶有一个30.1毫米的囊肿,未见颈动脉或动脉瘤征象。诊断:甲状腺囊肿出血。
{"title":"[A patient with an acute swelling in the neck after coronary angiography].","authors":"Ruben Y Gabriëls, Merel van Sante, Vincent C Cappendijk","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 72-year-old man with no relevant medical history underwent coronary angiography for angina complaints. One day post-procedure, he developed a progressive, painless right-sided neck swelling. Ultrasound revealed a well-defined 30.1 mm cyst in the right thyroid lobe without connection to the carotid artery or signs of aneurysm. Diagnosis: thyroid cyst haemorrhage.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145550104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Work-focused health care]. [以工作为中心的医疗保健]。
Q4 Medicine Pub Date : 2025-09-18
Irene T M Lindenburg, Annelies E R C H Boonen, Ingrid E Fakkert, Veronique van Zelm, Kees A de Kock

Decent work contributes to health, security of existence and social prosperity. This also applies to the majority of people with (chronic) diseases. Attention for work is an important task for every healthcare provider. By identifying problems in the area of work and health in a timely manner, a healthcare provider can promote work capacity and recovery and possibly prevent absenteeism or disability. Moreover, work-focused health care also reaches the group of patients without supervision from a company or insurance doctor. This educational article offers healthcare providers tools to shape work-focused health care in their daily practice.

体面工作有助于健康、生存安全和社会繁荣。这也适用于大多数患有(慢性)疾病的人。对每个医疗保健提供者来说,关注工作是一项重要任务。通过及时发现工作和健康领域的问题,医疗保健提供者可以促进工作能力和康复,并可能防止缺勤或残疾。此外,以工作为重点的医疗保健也惠及病人群体,而无需公司或保险医生的监督。这篇教育文章为医疗保健提供者提供了在日常实践中塑造以工作为中心的医疗保健的工具。
{"title":"[Work-focused health care].","authors":"Irene T M Lindenburg, Annelies E R C H Boonen, Ingrid E Fakkert, Veronique van Zelm, Kees A de Kock","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Decent work contributes to health, security of existence and social prosperity. This also applies to the majority of people with (chronic) diseases. Attention for work is an important task for every healthcare provider. By identifying problems in the area of work and health in a timely manner, a healthcare provider can promote work capacity and recovery and possibly prevent absenteeism or disability. Moreover, work-focused health care also reaches the group of patients without supervision from a company or insurance doctor. This educational article offers healthcare providers tools to shape work-focused health care in their daily practice.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145550225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The percutaneous cordotomy: an effective oncological pain treatment in palliative care]. 经皮脐带切开术:姑息治疗中一种有效的肿瘤疼痛治疗方法。
Q4 Medicine Pub Date : 2025-09-16
Thom A H Eshuis, Hans Timmerman, Ruud Stellema, Egbert J M Klarenbeek, Anna K L Reyners, André P Wolff

Oncological pain in palliative care is common. This article presents a 61-year-old man with a Pancoast tumor which caused severe pain and impaired his quality of life. Multimodal analgesia was not effective due to a limited analgesic effect and side effects. After one year the patient underwent a percutaneous cordotomy which resulted in a complete and long-term pain relief and an improvement of social and physical functioning. Reflecting on this case, the patient might have benefited from an earlier referral to a pain clinic that performs the cordotomy. Timely referral is recommended to discuss the possibility of a cordotomy with the patient in the early palliative phase. During this phase, the patient can make a well-considered decision whether the advantages and disadvantages of analgesics still outweigh those of a cordotomy. Early treatment might lead to a longer and improved quality of life with less or without pain.

肿瘤疼痛在姑息治疗中很常见。这篇文章提出了一个61岁的男人与Pancoast肿瘤引起严重的疼痛和损害他的生活质量。由于镇痛效果有限和副作用,多模式镇痛效果不佳。一年后,患者接受了经皮脊髓切开术,彻底缓解了长期疼痛,改善了社交和身体功能。反思这个案例,病人可能会受益于早期转介到疼痛诊所进行脐带切开术。建议及时转诊,与患者讨论在早期姑息期切除脐带的可能性。在这一阶段,患者可以充分考虑止痛剂的利弊是否仍然大于切除脐带的利弊。早期治疗可能会延长寿命,改善生活质量,减少或消除疼痛。
{"title":"[The percutaneous cordotomy: an effective oncological pain treatment in palliative care].","authors":"Thom A H Eshuis, Hans Timmerman, Ruud Stellema, Egbert J M Klarenbeek, Anna K L Reyners, André P Wolff","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Oncological pain in palliative care is common. This article presents a 61-year-old man with a Pancoast tumor which caused severe pain and impaired his quality of life. Multimodal analgesia was not effective due to a limited analgesic effect and side effects. After one year the patient underwent a percutaneous cordotomy which resulted in a complete and long-term pain relief and an improvement of social and physical functioning. Reflecting on this case, the patient might have benefited from an earlier referral to a pain clinic that performs the cordotomy. Timely referral is recommended to discuss the possibility of a cordotomy with the patient in the early palliative phase. During this phase, the patient can make a well-considered decision whether the advantages and disadvantages of analgesics still outweigh those of a cordotomy. Early treatment might lead to a longer and improved quality of life with less or without pain.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145550210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Assessing agitation, preventing escalation]. [评估躁动,防止升级]。
Q4 Medicine Pub Date : 2025-09-11
Joep J J Ouwerkerk, Femke M J Gresnigt, Jeroen G Lijmer, Nicole Kraaijvanger

Agitated patients present a challenge in clinical practice. Management strategies vary depending on severity, ranging from (non-)verbal de-escalation to pharmacological sedation. This article outlines a stepwise approach to treating agitation, distinguishing between mild, moderate, and extreme agitation. Mild agitation can often be managed with verbal and non-verbal techniques, while moderate agitation may require anxiolytics or antipsychotics. Extreme agitation necessitates rapid and effective sedation, administered by trained healthcare professionals, to ensure the safety of both patients and caregivers. Midazolam is commonly used for extreme agitation; however, research suggests that droperidol may be more effective and safer. When this initial approach is ineffective, ketamine can be considered. This article provides practical guidelines for selecting the appropriate interventions to optimize both patient and caregiver safety and well-being.

躁动患者在临床实践中是一个挑战。管理策略根据严重程度而有所不同,从(非)口头降级到药物镇静。这篇文章概述了一种逐步治疗躁动的方法,区分轻度、中度和极端躁动。轻度的躁动通常可以用语言和非语言技术来控制,而中度的躁动可能需要抗焦虑药物或抗精神病药物。极端躁动需要快速和有效的镇静,由训练有素的医疗保健专业人员管理,以确保患者和护理人员的安全。咪达唑仑通常用于极端躁动;然而,研究表明氟哌啶醇可能更有效、更安全。当最初的方法无效时,可以考虑使用氯胺酮。本文提供了选择适当干预措施的实用指南,以优化患者和护理人员的安全和福祉。
{"title":"[Assessing agitation, preventing escalation].","authors":"Joep J J Ouwerkerk, Femke M J Gresnigt, Jeroen G Lijmer, Nicole Kraaijvanger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Agitated patients present a challenge in clinical practice. Management strategies vary depending on severity, ranging from (non-)verbal de-escalation to pharmacological sedation. This article outlines a stepwise approach to treating agitation, distinguishing between mild, moderate, and extreme agitation. Mild agitation can often be managed with verbal and non-verbal techniques, while moderate agitation may require anxiolytics or antipsychotics. Extreme agitation necessitates rapid and effective sedation, administered by trained healthcare professionals, to ensure the safety of both patients and caregivers. Midazolam is commonly used for extreme agitation; however, research suggests that droperidol may be more effective and safer. When this initial approach is ineffective, ketamine can be considered. This article provides practical guidelines for selecting the appropriate interventions to optimize both patient and caregiver safety and well-being.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Naevus of Ito in a Dutch adult]. [荷兰成人的伊藤痣]。
Q4 Medicine Pub Date : 2025-09-10
Daphne D N van der Hout, Joris A C Verkouteren

This case report describes the presence of an acquirednaevus of Ito on a 78-year-old Dutch male. Naevus of Ito is a blue-grey discolouration that most commonly presents on Asian individuals during childhood. It is exceedingly rare for this naevus to occur later in life in a non-Asian individual.

本病例报告描述一名78岁荷兰男性出现获得性伊藤病。伊藤痣是一种蓝灰色的变色,最常见于亚洲人的童年时期。在非亚洲人以后的生活中出现这种痣是极其罕见的。
{"title":"[Naevus of Ito in a Dutch adult].","authors":"Daphne D N van der Hout, Joris A C Verkouteren","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This case report describes the presence of an acquirednaevus of Ito on a 78-year-old Dutch male. Naevus of Ito is a blue-grey discolouration that most commonly presents on Asian individuals during childhood. It is exceedingly rare for this naevus to occur later in life in a non-Asian individual.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vitiligo].
Q4 Medicine Pub Date : 2025-09-08
Sanne E Uitentuis, Marcel W Bekkenk, Patrick M J H Kemperman, Albert Wolkerstorfer

Vitiligo is a chronic skin disease characterized by white patches caused by the destruction of melanocytes. The most well-known variant is non-segmental vitiligo, where patches are symmetrically distributed across the entire body, with alternating periods of stability and progression. The white patches arise due to an autoimmune reaction in which cytotoxic T-cells attack the melanocytes. Treatment aims to halt the progression and to achieve repigmentation of existing lesions. The treatment often consists of a combination of topical therapy and phototherapy, sometimes supplemented by systemic corticosteroids or surgical techniques. However, recently new treatments have entered the market, notably treatment with JAK inhibitors (both topical and systemic), with promising results.

白癜风是一种慢性皮肤病,其特征是由黑色素细胞破坏引起的白色斑块。最著名的变种是非节段性白癜风,其中斑块对称分布在整个身体,具有稳定和进展交替的时期。白色斑块是由于细胞毒性t细胞攻击黑素细胞的自身免疫反应而产生的。治疗的目的是停止进展,并实现现有病变的重新着色。治疗通常包括局部治疗和光疗的结合,有时辅以全身皮质类固醇或手术技术。然而,最近新的治疗方法已经进入市场,特别是使用JAK抑制剂治疗(局部和全身),结果很有希望。
{"title":"[Vitiligo].","authors":"Sanne E Uitentuis, Marcel W Bekkenk, Patrick M J H Kemperman, Albert Wolkerstorfer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Vitiligo is a chronic skin disease characterized by white patches caused by the destruction of melanocytes. The most well-known variant is non-segmental vitiligo, where patches are symmetrically distributed across the entire body, with alternating periods of stability and progression. The white patches arise due to an autoimmune reaction in which cytotoxic T-cells attack the melanocytes. Treatment aims to halt the progression and to achieve repigmentation of existing lesions. The treatment often consists of a combination of topical therapy and phototherapy, sometimes supplemented by systemic corticosteroids or surgical techniques. However, recently new treatments have entered the market, notably treatment with JAK inhibitors (both topical and systemic), with promising results.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sex differences in the pharmacological treatment of hypertension in primary care]. [初级保健中高血压药物治疗的性别差异]。
Q4 Medicine Pub Date : 2025-09-03
Elisa Dal Canto, Sophie L Theunisse, Michiel L Bots, Frans H Rutten, Marion C J Biermans, N Charlotte Onland-Moret, Wilko Spiering, Birsen Kiliç, Hester M den Ruijter, Monika Hollander

Objective: To investigate sex differences in the pharmacological treatment of hypertension in primary care.

Design: Cross-sectional study among 14,384 patients with hypertension from the Julius General Practitioners' Network, without cardiovascular disease or diabetes, treated with antihypertensive medications.

Methods: We compared men and women in the number and type of prescribed antihypertensives and their blood pressure.

Results: Women (n=8596) and men (n=5788) were prescribed the same number of antihypertensive agents on average (1.8). Women received lower dosages, more often beta-blockers (35% vs. 26%, p<0.001) and diuretics (54% vs. 51%, p<0.001), but less often ACE inhibitors (35% vs. 46%, p<0.001) and calcium channel blockers (29% vs. 36%, p<0.001). Blood pressure control was more often achieved in women than in men (50% vs. 46%, p<0.001).

Conclusion: Although current guidelines do not distinguish between sexes, differences exist in the type and dosage of antihypertensives prescribed, and in the rate of blood pressure control.

目的:探讨初级保健中高血压药物治疗的性别差异。设计:对来自Julius全科医生网络的14384例高血压患者进行横断面研究,这些患者无心血管疾病或糖尿病,接受降压药物治疗。方法:我们比较了男性和女性处方降压药的数量和种类以及他们的血压。结果:女性(8596)与男性(5788)的平均降压药处方数相同(1.8)。结论:尽管目前的指南没有区分性别,但在抗高血压药物的类型和剂量以及血压控制率方面存在差异。
{"title":"[Sex differences in the pharmacological treatment of hypertension in primary care].","authors":"Elisa Dal Canto, Sophie L Theunisse, Michiel L Bots, Frans H Rutten, Marion C J Biermans, N Charlotte Onland-Moret, Wilko Spiering, Birsen Kiliç, Hester M den Ruijter, Monika Hollander","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate sex differences in the pharmacological treatment of hypertension in primary care.</p><p><strong>Design: </strong>Cross-sectional study among 14,384 patients with hypertension from the Julius General Practitioners' Network, without cardiovascular disease or diabetes, treated with antihypertensive medications.</p><p><strong>Methods: </strong>We compared men and women in the number and type of prescribed antihypertensives and their blood pressure.</p><p><strong>Results: </strong>Women (n=8596) and men (n=5788) were prescribed the same number of antihypertensive agents on average (1.8). Women received lower dosages, more often beta-blockers (35% vs. 26%, p<0.001) and diuretics (54% vs. 51%, p<0.001), but less often ACE inhibitors (35% vs. 46%, p<0.001) and calcium channel blockers (29% vs. 36%, p<0.001). Blood pressure control was more often achieved in women than in men (50% vs. 46%, p<0.001).</p><p><strong>Conclusion: </strong>Although current guidelines do not distinguish between sexes, differences exist in the type and dosage of antihypertensives prescribed, and in the rate of blood pressure control.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[BRASH syndrome: the vicious cycle of bradycardia, hyperkalemia and renal failure]. [BRASH综合征:心动过缓、高钾血症和肾衰竭的恶性循环]。
Q4 Medicine Pub Date : 2025-09-02
Tamar J A Kooger, Linda de Nooij, Ernesto Gilly Simon

BRASH syndrome is an acronym for Bradycardia, Renal failure, AV blockade, Shock, and Hyperkalemia. It arises from the synergy between AV nodal blocking medications (such as beta-blockers or calcium antagonists), renal failure, and hyperkalemia, leading to bradycardia and renal hypoperfusion. This exacerbates the decline in renal function and hyperkalemia, increasing the effect of AV-node blocking medication and creating a vicious cycle with the risk of multi-organ failure. Patients often improve with basic supportive therapy, such as discontinuing AV nodal blockers, correcting hyperkalemia, and rehydration. We present a case that highlights the importance of early recognition of this often-overlooked syndrome in patients with combined cardiovascular and renal comorbidities.

BRASH综合征是心动过缓、肾功能衰竭、房室传导阻滞、休克和高钾血症的首字母缩略词。它源于房室结阻断药物(如-受体阻滞剂或钙拮抗剂)、肾功能衰竭和高钾血症之间的协同作用,导致心动过缓和肾灌注不足。这加剧了肾功能和高钾血症的下降,增加了av节点阻断药物的作用,并造成了多器官衰竭风险的恶性循环。患者通常通过基本的支持治疗得到改善,如停用房室结阻滞剂、纠正高钾血症和补液。我们提出一个病例,强调早期识别这种经常被忽视的综合征在合并心血管和肾脏合并症患者的重要性。
{"title":"[BRASH syndrome: the vicious cycle of bradycardia, hyperkalemia and renal failure].","authors":"Tamar J A Kooger, Linda de Nooij, Ernesto Gilly Simon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BRASH syndrome is an acronym for Bradycardia, Renal failure, AV blockade, Shock, and Hyperkalemia. It arises from the synergy between AV nodal blocking medications (such as beta-blockers or calcium antagonists), renal failure, and hyperkalemia, leading to bradycardia and renal hypoperfusion. This exacerbates the decline in renal function and hyperkalemia, increasing the effect of AV-node blocking medication and creating a vicious cycle with the risk of multi-organ failure. Patients often improve with basic supportive therapy, such as discontinuing AV nodal blockers, correcting hyperkalemia, and rehydration. We present a case that highlights the importance of early recognition of this often-overlooked syndrome in patients with combined cardiovascular and renal comorbidities.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How sustainable is our oncological care?] 我们的肿瘤治疗可持续性如何?]
Q4 Medicine Pub Date : 2025-08-28
Femke A Van der Zant, Johanna W M Aarts, Schelto Kruijff, Hanneke Van Laarhoven, Matthijs Versteegh, Wouter J K Hehenkamp

In the face of increasing patient demands and the urgent threat of climate change, this article critically examines the current challenges within oncology. The authorsadvocate for a sustainable healthcare system that balances patient care with environmental responsibilities. Highlighting the significant carbon footprint of oncology, driven by costly treatments and pharmaceuticals, the authors argue that the pursuit of aggressive, life-extending therapies often conflicts with goals of accessibility and sustainability. To mitigate these issues, the article proposes a four-tier roadmap for reducing the environmental impact of oncological care: (1) assessing societal impacts; (2) engaging patients in discussions on personal values; (3) incorporating sustainability in professional standards; and (4) implementing dosage reduction strategies. This approach aims to align oncology practices with sustainable healthcare objectives, ensuring responsible care for future generations.

面对日益增长的患者需求和气候变化的紧迫威胁,本文批判性地审视了肿瘤学目前面临的挑战。作者提倡一个可持续的医疗保健系统,平衡病人护理与环境责任。作者强调了由昂贵的治疗和药物驱动的肿瘤学的巨大碳足迹,他们认为,追求积极的、延长生命的治疗往往与可获得性和可持续性的目标相冲突。为了缓解这些问题,本文提出了一个四层路线图,以减少肿瘤护理的环境影响:(1)评估社会影响;(2)让患者参与个人价值观的讨论;(3)将可持续性纳入专业标准;(4)实施减量策略。这种方法旨在使肿瘤学实践与可持续的医疗保健目标保持一致,确保为子孙后代提供负责任的护理。
{"title":"[How sustainable is our oncological care?]","authors":"Femke A Van der Zant, Johanna W M Aarts, Schelto Kruijff, Hanneke Van Laarhoven, Matthijs Versteegh, Wouter J K Hehenkamp","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the face of increasing patient demands and the urgent threat of climate change, this article critically examines the current challenges within oncology. The authorsadvocate for a sustainable healthcare system that balances patient care with environmental responsibilities. Highlighting the significant carbon footprint of oncology, driven by costly treatments and pharmaceuticals, the authors argue that the pursuit of aggressive, life-extending therapies often conflicts with goals of accessibility and sustainability. To mitigate these issues, the article proposes a four-tier roadmap for reducing the environmental impact of oncological care: (1) assessing societal impacts; (2) engaging patients in discussions on personal values; (3) incorporating sustainability in professional standards; and (4) implementing dosage reduction strategies. This approach aims to align oncology practices with sustainable healthcare objectives, ensuring responsible care for future generations.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Single digit nail clubbing]. [单指指甲棍]。
Q4 Medicine Pub Date : 2025-08-27
Nieke N P M Smeins, Tim Pruimboom, Frank S van Leersum

A 33-year old woman presented with a slowly progressive but asymptomatic nail disorder of the left index finger. MRI and histological examination revealed a subungual neurofibroma as the cause of this single digit clubbing. Surgical removal resulted in good recovery with preservation of the nail.

一位33岁的女性表现为缓慢进展但无症状的左食指指甲疾病。MRI和组织学检查显示一个趾骨下神经纤维瘤的原因,这一单指的俱乐部。手术切除后恢复良好,保留了指甲。
{"title":"[Single digit nail clubbing].","authors":"Nieke N P M Smeins, Tim Pruimboom, Frank S van Leersum","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 33-year old woman presented with a slowly progressive but asymptomatic nail disorder of the left index finger. MRI and histological examination revealed a subungual neurofibroma as the cause of this single digit clubbing. Surgical removal resulted in good recovery with preservation of the nail.</p>","PeriodicalId":18903,"journal":{"name":"Nederlands tijdschrift voor geneeskunde","volume":"169 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nederlands tijdschrift voor geneeskunde
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1